You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1516438 |
---|---|
Category | Proteins |
Description | Recombinant human ErbB2 / Her2 protein, C-His-Avi (HEK293) |
Tag | C-His-Avi |
Concentration | > 0.5 mg/ml |
Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC |
MW | Due to glycosylation, the protein migrates to 80-100 kDa based on Tris-Bis PAGE result. kDa |
Target | Receptor tyrosine-protein kinase erbB-2 |
Protein Sequence | 23-652/1255 |
Expression System | HEK293 cell |
Endotoxins | < 1.0 EU/μg as determined by LAL |
Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
Alternative names | erbB-2 isoform 2; HER2 receptor; Erbb2 protein; Ce Read more... |
Note | For research use only |
Application notes | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Expiration Date | 6 months from date of receipt. |
Immobilized Human Her2, His Tag at 0.2 µg/ml (100 µl/Well). Dose response curve for Anti-Her2 Ab. Trastuzumab, with the EC50 of 17.4 ng/ml determined by ELISA.
Immobilized Human Her2, His Tag at 0.2 µg/ml (100 µl/Well). Dose response curve for Anti-Her2 Ab. with the EC50 of 15.9 ng/ml/15.0 ng/ml/15.7 ng/ml determined by ELISA.
Recombinant Human ErbB2/Her2 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant Human ErbB2/Her2 Protein is greater than 95% as determined by SEC-HPLC.
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC | |
Due to glycosylation, the protein migrates to 80-100 kDa based on Tris-Bis PAGE result. kDa |